Thanks for your interest in ChatRWD
We appreciate your interest in Atropos Health’s new AI-powered chat-to-database application, ChatRWD.
We will be in touch with you within the next business day.
Resources
Check out our latest press releases, news and media coverage, videos and blog
Transparency, along with accuracy, quality and speed are what drive us. Read about our methods, results and technology to see how we can partner to improve the use of RWE in healthcare today.
Association Between Semaglutide and Risk of Bone Fractures in Type 2 Diabetes
A study titled “Association Between Semaglutide and Risk of Bone Fractures in Type 2 Diabetes” was presented at the Endocrine...
Atropos Health Expands Partnership with Databricks with the Launch of the Atropos Evidence Agent MCP on Databricks Marketplace
Atropos Health and Databricks have expanded their partnership, bringing the Atropos Evidence Agent MCP directly to the...